Table 1.
CI steps | TB control jurisdictions
|
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | |
Medical record review | ❍ | ❏ | ❏ | ❍ | ❏ | ● | ❍ | ❍ | ❏ | ||
Period of infectiousness assessed | ❍ | ❍ | ❍ | ❍ | |||||||
Patient interview conducted | ❍ | ❍ | ❍ | ❍ | ❍ | ❍ | ❍ | ❍ | ❍ | ||
Confidentiality | ❍ | ❍ | ❍ | ❍ | |||||||
Patient education | ❍ | ❍ | ● | ❍ | ❍ | ||||||
Second interview | ❍ | ❍ | ❍ | ❍ | ❍ | ❍ | ❍ | ||||
Field visits required | ❍ | ❍ | ◆ | ❍ | ● | ❍ | ❍ | ❍ | ◆ | ||
Routine TST in field | ❍ | ❍ | ❍ | ◆ | ❍ | ❍ | |||||
Contact education | ❍ | ❍ | ❍ | ❍ | ❍ | ◆ | ◆ | ||||
Risk assessment for TB transmission | ❍ | ❍ | ❍ | ❍ | ❍ | ❍ | ❍ | ❍ | ❍ | ❍ | ❍ |
Prioritizing contacts | ● | ● | ● | ❍ | ● | ● | ❍ | ❍ | ❍ | ● | ❍ |
Steps to locate contacts | ❍ | ❍ | ❍ | ❍ | ❍ | ||||||
HIV risk assessments and referrals to testing | ❍ | ❍ | ❍ | ❍ | ● | ||||||
Evaluating contacts | ❍ | ❍ | ● | ● | ● | ❍ | ● | ● | ❍ | ||
Second TST | ❍ | ❍ | ❍ | ❏ | ❍ | ❍ | ❍ | ❍ | ❍ | ❍ | |
Screen patients with history of TST+ | ❍ | ❍ | ❍ | ❍ | ❍ | ❍ | |||||
Treatment and follow-up of contacts | ❍ | ❍ | ❍ | ❍ | ● | ❍ | ❍ | ❍ | ❍ | ||
Specialized treatment for children | ❍ | ❍ | ❍ | ❍ | ❍ | ❍ | ❍ | ◆ | |||
Specialized treatment for HIV+ individuals | ❏ | ❍ | ❍ | ❍ | ❍ | ❍ | |||||
Barriers to adherence identified | ❍ | ❏ | ❏ | ❍ | ❍ | ❏ | |||||
Rules for expansion | ❍ | ❍ | ❍ | ||||||||
Concentric circle approach | ❍ | ❍ | ❍ | ◆ | ❍ |
● Specific ❍General ❏ Form only ◆ Special circumstances/populations